Short-Term changes in the hormonal profile and OPG-RANKL system in osteoporotic patients treated with raloxifene
D. Fernández*1, P. Mezquita-Raya*1, M. de la Higuera*1, R. Reyes*1, G. Alonso*1, M. Ruiz-Requena*2, F. Escobar-Jiménez*1 and M. Muñoz-Torres1
1Bone Metabolic Unit. Department of Endocrinology, University Hospital San Cecilio, Granada, Spain, 2Biochemistry Division, University Hospital San Cecilio, Granada, Spain.
Low performance of circulating RANKL to identify postmenopausal women with osteoporosis and pre-existing vertebral fractures
P. Mezquita-Raya*1, M. de la Higuera*1, D. Fernández*1, G. Alonso*1, M. Ruiz-Requena*2, F. Escobar-Jiménez1 and M. Muñoz-Torres1.
1Bone Metabolic Unit. Department of Endocrinology, University Hospital San Cecilio, Granada, Spain, 2Biochemistry Division, University Hospital San Cecilio, Granada, Spain.
The polymorphisms of the vdr cdx-2 influence bone mineral density (BMD) in postmenopausal women
J. M. Quesada-Gómez*/**, A. Casado */**, R. Cuenca-Acevedo*, L. Barrios*, C. Díaz-Molina* and G. Dorado***
*Unidad Metabolismo Mineral, Hospital Reina Sofía, Córdoba; **Unidad I+D+I Sanyres (Grupo PRASA); and ***Dep. Bioquímica y Biología Molecular, Universidad de Córdoba, Córdoba, Spain.
Osteoprotegerin Levels In Cirrhotic Patients Referred For Orthotopic Liver Transplantation
A. Monegal, N. Guañabens, M. Navasa, L. Álvarez, D. Ozalla, P. Peris and J. Rodés
Metabolic Bone Diseases and Liver Units. Hospital Clínic. IDIBAPS. University of Barcelona. Spain.
Different Responses Of Bone Turnover Markers To Bisphosphonate Therapy In Pagetic Patients With Skull Involvement
L. Álvarez1, P. Peris2, N. Guañabens2, S. Vidal-Sicart*3, H. Solberg*4, P. Cloos*4, A. Monegal*2, J. Bedini*1, F. Pons*3 and A. Ballesta*1
1Biochemistry, Hospital Clinic, Barcelona, Spain, 2Rheumatology, Hospital Clinic, Barcelona, Spain, 3Nuclear Medicine, Hospital Clinic, Barcelona, Spain, 4Nordic Bioscience, Herlev, Denmark.
Anabolic Effects of Intermittent Parathyroid Hormone-Related Protein (107-139) (Osteostatin) on Human Osteoblastic Cells in Vitro
A. R. de Gortázar*, V. Alonso* and P. Esbrit
Bone and Mineral Metabolism Laboratory, Fundación Jiménez Díaz-UTE, Madrid, Spain.
Correlation Between Bone Mineral Density (BMD) and Gene Expression of OPG-RANKL of Human Osteoblast Cultures from Postmenopausal Women
S. Ruiz-Gaspà*, A. Enjuanes*, J. C. Monllau*, E. Cáceres*, M. Payes*, J. Vila*, L. Mellibovsky*, J. Blanch, I. Aymar*, A. Díez-Pérez and X. Nogués
Urfoa, IMIM-Hospital del Mar, Barcelona, Spain.
Is the Effect of Raloxifene and Estrogen on Bone Mediated by a Differential Expression of Estrogen Receptors?
M. Naves*, A. Rodríguez-Rodríguez*, C. Gómez, A. González-Carcedo*, N. Carrillo-López* and J. B. Cannata-Andía
Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Oviedo, Spain.
Is The Nulliparity A Risk Factor For Osteoporotic Fracture In Post Menopausal Women?
L. del Río, S. di Gregorio and J. Rosales
Cetir Centre Mèdic. Barcelona Spain.
Interleukin 1ß -511 C/T polymorphysm is related to the response to bisphosphonate treatment in Paget disease of bone (PDB)
L. Corral-Gudino2, J. del Pino-Montes*1 , R. González-Sarmiento*3, C. A. Montilla*1, I. Pastor*2 and J. García-Aparicio*2.
1Medicine. Rheumatology, University Hospital. Universidad de Salamanca, Salamanca, Spain, 2Medicine, University Hospital. Universidad de Salamanca, Salamanca, Spain, 3Medicine, Universidad de Salamanca, Salamanca, Spain.
Effects of PTH on Bone Architecture and Bone Mass in Orchidectomized Rats
S. Gómez, M. Díaz-Curiel, C. de la Piedra, D. Serfati, M. Montero, F. Pérez Martínez, S. Luna and J. García.
Facultad de Medicina Universidad de Cádiz, Cádiz, Spain. Medicina Interna Fundación Jiménez Díaz, Madrid, Spain. Fisiopatología Ósea Fundación Jiménez Díaz, Madrid, Spain. Medicina Experimental, Fundación Jiménez Díaz, Madrid, Spain. Facultad de Medicina Universidad de Cádiz, Cádiz, Spain, Facultad de Medicina Universidad de Granada, Granada,Spain.
Osteoporotic fracture prevalence in an area of Barcelona (Spain). Relationship with peripheric densitometry and risk of fracture questionnary
M. Ciria, L. Pérez-Edo, J. Blanch, M. Coll, J. Carbonell, I. González* and J. Fernández**
Servei de Reumatología de l'IMAS, *ABS Baix Guinardó, Barcelona, **ABS Besós, Barcelona, Spain.